BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2469084)

  • 1. Influence of iloprost on eicosanoid generation and lipid levels in experimental myocardial ischemia in dogs.
    Beitz A; Taube C; Beitz J; Goos H; Graff J; Nöhring J; Lindenau KF; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):141-5. PubMed ID: 2469084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris.
    Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S
    Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of drugs on the TXA2/PGI2 balance and on the atherogenic index in myocardial ischemia in dogs.
    Beitz A; Taube C; Beitz J; Goos H; Graff J; Nohring J; Lindenau KF; Mest HJ
    Biomed Biochim Acta; 1988; 47(10-11):S149-52. PubMed ID: 2470353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in TXB2/6-keto-PGF1 alpha ratio and their relation to blood lipids of Type A behavioral patterns].
    Deng X; Luo D; Li Y; Lian S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):414-7. PubMed ID: 8150445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
    Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of prostacyclin and thromboxane A2 release during reperfusion after global ischemia induced by crystalloid cardioplegia--comparison between warm and cold ischemia.
    Nomura F; Matsuda H; Hirose H; Shirakura R; Ohtani M; Kaneko M; Kawashima Y
    Eur Surg Res; 1988; 20(2):110-9. PubMed ID: 3292253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
    Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
    Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of experimental coronary artery stenosis on platelet function].
    Chen SL; Zang YM; Zhu MZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Oct; 17(5):285-7, 318. PubMed ID: 2636126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse.
    Clark WF; Parbtani A; McDonald JW; Taylor N; Reid BD; Kreeft J
    Clin Nephrol; 1987 Dec; 28(6):288-94. PubMed ID: 2450713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoids and hemodynamics in man before and during cardiopulmonary bypass.
    Uotila P; Suyes M; Heikkilä H; Jalonen J
    Prostaglandins; 1984 Oct; 28(4):497-508. PubMed ID: 6335260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cardiac sympathetic nerves on changes of TXB2 and 6-keto-PGF1 alpha in venous blood of ischemic myocardium].
    Zhao ZQ; Zang YM; Wang FZ; Li ZJ; Yang MF; Ma SY
    Sheng Li Xue Bao; 1989 Feb; 41(1):30-9. PubMed ID: 2762830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of the prostacyclin and thromboxane system, lipid metabolism and lipid peroxidation processes in patients with coronary atherosclerosis].
    Efimov VV; Ladnyĭ AI
    Vrach Delo; 1986 Apr; (4):37-40. PubMed ID: 3754994
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery.
    Tada M; Esumi K; Yamagishi M; Kuzuya T; Matsuda H; Abe H; Uchida Y; Murao S
    J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    J Mol Cell Cardiol; 1984 Jan; 16(1):43-52. PubMed ID: 6366241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of iloprost in the stunned canine myocardium.
    Farber NE; Pieper GM; Thomas JP; Gross GJ
    Circ Res; 1988 Feb; 62(2):204-15. PubMed ID: 2448057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PGI2 and thromboxane antagonist on liver ischemic injury.
    Besse T; Gustin T; Claeys N; Schroeyers P; Lambotte L
    Eur Surg Res; 1989; 21(3-4):213-7. PubMed ID: 2478369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease.
    Chen LS; Ito T; Ogawa K; Satake T
    Jpn Circ J; 1982 Jul; 46(7):651-6. PubMed ID: 6896534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
    Parratt JR; Coker SJ; Wainwright CL
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.